CELC
Celcuity Inc.
Price Chart
No historical data available
Latest Quote
$90.71
+1.65 (+1.85%)
Current Price
| Previous Close | $89.06 |
| Open | $89.00 |
| Day High | $91.03 |
| Day Low | $88.64 |
| Volume | 350,289 |
Stock Information
| Shares Outstanding | 48.93M |
| Total Debt | $754.39M |
| Cash Equivalents | $754.04M |
| Net Income | $-226.48M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $4.44B |
| EPS (TTM) | $-4.30 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Celcuity Inc.
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.
đ° Latest News
No news articles available at the moment. Check back later for updates on CELC.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $17,148,000 | $10,280,000 | $5,326,387 | $2,106,111 |
| Total Expenses | $172,192,000 | $113,267,000 | $66,230,331 | $39,391,091 |
| Net Non Operating Interest Income Expense | $-4,850,000 | $1,488,000 | $2,451,215 | $-978,949 |
| Interest Expense Non Operating | $17,148,000 | $10,280,000 | $5,326,387 | $2,106,111 |
| Operating Expense | $172,192,000 | $113,267,000 | $66,230,331 | $39,391,091 |
| General And Administrative Expense | $27,197,000 | $9,064,000 | $5,636,326 | $4,101,543 |
| Other Income Expense | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Net Interest Income | $-4,850,000 | $1,488,000 | $2,451,215 | $-978,949 |
| Interest Income | $12,298,000 | $11,768,000 | $7,777,602 | $1,127,162 |
| Normalized Income | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Net Income From Continuing And Discontinued Operation | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Total Operating Income As Reported | $-172,192,000 | $-113,267,000 | $-66,230,331 | $-39,391,091 |
| Net Income Common Stockholders | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Net Income | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Net Income Including Noncontrolling Interests | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Net Income Continuous Operations | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Pretax Income | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Interest Income Non Operating | $12,298,000 | $11,768,000 | $7,777,602 | $1,127,162 |
| Operating Income | $-172,192,000 | $-113,267,000 | $-66,230,331 | $-39,391,091 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-3.79 | $-2.83 | $-2.69 | $-2.64 |
| Basic EPS | $-3.79 | $-2.83 | $-2.69 | $-2.64 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-159,727,000 | $-101,369,000 | $-58,309,957 | $-38,053,011 |
| Reconciled Depreciation | $167,000 | $130,000 | $142,772 | $210,918 |
| EBITDA (Bullshit earnings) | $-159,727,000 | $-101,369,000 | $-58,309,957 | $-38,053,011 |
| EBIT | $-159,894,000 | $-101,499,000 | $-58,452,729 | $-38,263,929 |
| Diluted Average Shares | $46,757,691 | $39,449,393 | $23,679,472 | $15,418,543 |
| Basic Average Shares | $46,757,691 | $39,449,393 | $23,679,472 | $15,418,543 |
| Diluted NI Availto Com Stockholders | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Research And Development | $144,995,000 | $104,203,000 | $60,594,005 | $35,289,548 |
| Selling General And Administration | $27,197,000 | $9,064,000 | $5,636,326 | $4,101,543 |
| Other Gand A | $27,197,000 | $9,064,000 | $5,636,326 | $4,101,543 |
| Total Unusual Items | - | - | - | $0 |
| Total Unusual Items Excluding Goodwill | - | - | - | $0 |
| Gain On Sale Of Ppe | - | - | - | $0 |
Fetched: 2026-08-28
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $100,555,000 | $115,619,000 | $139,769,322 | $133,771,467 |
| Total Assets | $466,558,000 | $245,123,000 | $191,219,398 | $175,697,097 |
| Total Non Current Assets | $899,000 | $552,000 | $628,801 | $506,560 |
| Other Non Current Assets | $349,000 | - | - | - |
| Current Assets | $465,659,000 | $244,571,000 | $190,590,597 | $175,190,537 |
| Other Current Assets | $5,266,000 | $2,698,000 | $281,364 | $351,073 |
| Prepaid Assets | $18,896,000 | $6,769,000 | $8,920,603 | $6,251,953 |
| Cash Cash Equivalents And Short Term Investments | $441,497,000 | $235,104,000 | $180,582,748 | $168,587,511 |
| Cash And Cash Equivalents | $165,703,000 | $22,515,000 | $30,662,774 | $24,571,557 |
| Receivables | - | $1,600,621 | $805,882 | $0 |
| Other Receivables | - | $1,600,621 | $805,882 | - |
| Current Deferred Assets | - | - | - | $33,195 |
| Taxes Receivable | - | - | - | $203,665 |
| Debt | ||||
| Net Debt | $156,148,000 | $75,212,000 | $6,372,637 | $10,411,517 |
| Total Debt | $321,905,000 | $97,953,000 | $37,446,283 | $35,238,274 |
| Long Term Debt And Capital Lease Obligation | $321,851,000 | $97,781,000 | $37,261,333 | $35,044,076 |
| Long Term Debt | $321,851,000 | $97,727,000 | $37,035,411 | $34,983,074 |
| Current Debt And Capital Lease Obligation | $54,000 | $172,000 | $184,950 | $194,198 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $366,003,000 | $129,504,000 | $51,450,076 | $41,925,630 |
| Total Non Current Liabilities Net Minority Interest | $321,851,000 | $97,781,000 | $37,261,333 | $35,044,076 |
| Current Liabilities | $44,152,000 | $31,723,000 | $14,188,743 | $6,881,554 |
| Payables And Accrued Expenses | $35,760,000 | $27,459,000 | $12,182,983 | $5,719,173 |
| Interest Payable | $3,379,000 | - | - | - |
| Payables | $6,407,000 | $9,366,000 | $5,076,699 | $2,627,076 |
| Accounts Payable | $6,407,000 | $9,366,000 | $5,076,699 | $2,627,076 |
| Equity | ||||
| Common Stock Equity | $100,555,000 | $115,619,000 | $139,768,468 | $133,770,346 |
| Total Equity Gross Minority Interest | $100,555,000 | $115,619,000 | $139,769,322 | $133,771,467 |
| Stockholders Equity | $100,555,000 | $115,619,000 | $139,769,322 | $133,771,467 |
| Retained Earnings | $-448,897,000 | $-271,855,000 | $-160,076,003 | $-96,296,887 |
| Preferred Stock Equity | - | $318 | $854 | $1,121 |
| Other | ||||
| Ordinary Shares Number | $48,244,960 | $37,143,242 | $25,506,012 | $21,667,250 |
| Share Issued | $48,244,960 | $37,143,242 | $25,506,012 | $21,667,250 |
| Tangible Book Value | $100,555,000 | $115,619,000 | $139,768,468 | $133,770,346 |
| Invested Capital | $422,406,000 | $213,346,000 | $176,803,879 | $168,753,420 |
| Working Capital | $421,507,000 | $212,848,000 | $176,401,854 | $168,308,983 |
| Capital Lease Obligations | $54,000 | $226,000 | $410,872 | $255,200 |
| Total Capitalization | $422,406,000 | $213,346,000 | $176,804,733 | $168,754,541 |
| Additional Paid In Capital | $549,404,000 | $387,437,000 | $299,818,965 | $230,045,566 |
| Capital Stock | $48,000 | $37,000 | $26,360 | $22,788 |
| Common Stock | $48,000 | $37,000 | $25,506 | $21,667 |
| Preferred Stock | $0 | $0 | $854 | $1,121 |
| Long Term Capital Lease Obligation | $0 | $54,000 | $225,922 | $61,002 |
| Current Capital Lease Obligation | $54,000 | $172,000 | $184,950 | $194,198 |
| Pensionand Other Post Retirement Benefit Plans Current | $8,338,000 | $4,092,000 | $1,820,810 | $968,183 |
| Current Accrued Expenses | $29,353,000 | $18,093,000 | $7,106,284 | $3,092,097 |
| Net PPE | $550,000 | $552,000 | $628,801 | $506,560 |
| Accumulated Depreciation | $-2,159,000 | $-1,992,000 | $-1,861,990 | $-1,719,218 |
| Gross PPE | $2,709,000 | $2,544,000 | $2,490,791 | $2,225,778 |
| Leases | $304,000 | $303,000 | $302,577 | $302,577 |
| Other Properties | $51,000 | $216,000 | $400,019 | $246,266 |
| Machinery Furniture Equipment | $2,354,000 | $2,025,000 | $1,788,195 | $1,676,935 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $275,794,000 | $212,589,000 | $149,919,974 | $144,015,954 |
Fetched: 2026-08-28
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-153,529,000 | $-83,717,000 | $-53,909,897 | $-36,166,939 |
| Operating Activities | ||||
| Operating Cash Flow | $-153,280,000 | $-83,467,000 | $-53,812,253 | $-36,008,171 |
| Cash Flow From Continuing Operating Activities | $-153,280,000 | $-83,467,000 | $-53,812,253 | $-36,008,171 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-249,000 | $-250,000 | $-97,644 | $-158,768 |
| Investing Cash Flow | $-64,084,000 | $-63,069,000 | $-5,008,207 | $-144,031,794 |
| Cash Flow From Continuing Investing Activities | $-64,084,000 | $-63,069,000 | $-5,008,207 | $-144,031,794 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $91,592,000 | $63,608,000 | $14,431,186 | $100,497,832 |
| Financing Cash Flow | $360,552,000 | $138,388,000 | $64,911,677 | $120,325,141 |
| Cash Flow From Continuing Financing Activities | $360,552,000 | $138,388,000 | $64,911,677 | $120,325,141 |
| Net Other Financing Charges | $-46,000 | $-228,000 | $-48,521 | - |
| Net Common Stock Issuance | $91,592,000 | $63,608,000 | $14,431,186 | $100,497,832 |
| Common Stock Issuance | $91,592,000 | $63,608,000 | $14,431,186 | $100,497,832 |
| Other | ||||
| Issuance Of Debt | $222,749,000 | $59,226,000 | $0 | $19,509,037 |
| Interest Paid Supplemental Data | $10,348,000 | $7,586,000 | $3,274,051 | $1,255,280 |
| End Cash Position | $165,703,000 | $22,515,000 | $30,662,774 | $24,571,557 |
| Beginning Cash Position | $22,515,000 | $30,663,000 | $24,571,557 | $84,286,381 |
| Changes In Cash | $143,188,000 | $-8,148,000 | $6,091,217 | $-59,714,824 |
| Proceeds From Stock Option Exercised | $46,257,000 | $15,782,000 | $50,531,461 | $324,122 |
| Net Issuance Payments Of Debt | $222,749,000 | $59,226,000 | $-2,449 | $19,503,187 |
| Net Long Term Debt Issuance | $222,749,000 | $59,226,000 | $-2,449 | $19,503,187 |
| Long Term Debt Issuance | $222,749,000 | $59,226,000 | $0 | $19,509,037 |
| Net Investment Purchase And Sale | $-63,835,000 | $-62,819,000 | $-4,910,563 | $-143,873,026 |
| Sale Of Investment | $332,507,000 | $642,346,000 | $309,614,521 | $0 |
| Purchase Of Investment | $-396,342,000 | $-705,165,000 | $-314,525,084 | $-143,873,026 |
| Net PPE Purchase And Sale | $-249,000 | $-250,000 | $-97,644 | $-158,768 |
| Purchase Of PPE | $-249,000 | $-250,000 | $-97,644 | $-158,768 |
| Change In Working Capital | $-2,652,000 | $18,349,000 | $3,859,410 | $-1,191,914 |
| Change In Other Current Assets | $-2,991,000 | $2,770,000 | $-3,438,018 | $-5,526,381 |
| Change In Payables And Accrued Expense | $12,466,000 | $17,573,000 | $7,297,428 | $4,334,467 |
| Change In Accrued Expense | $15,506,000 | $13,257,000 | $4,866,814 | $3,257,387 |
| Change In Payable | $-3,040,000 | $4,316,000 | $2,430,614 | $1,077,080 |
| Change In Account Payable | $-3,040,000 | $4,316,000 | $2,430,614 | $1,077,080 |
| Change In Prepaid Assets | $-12,127,000 | $-1,994,000 | - | $-5,621,480 |
| Other Non Cash Items | $4,864,000 | $2,845,000 | $1,063,247 | $704,660 |
| Stock Based Compensation | $21,383,000 | $6,988,000 | $4,901,434 | $4,638,205 |
| Depreciation Amortization Depletion | $167,000 | $130,000 | $142,772 | $210,918 |
| Depreciation And Amortization | $167,000 | $130,000 | $142,772 | $210,918 |
| Depreciation | $167,000 | $130,000 | $142,772 | $210,918 |
| Net Income From Continuing Operations | $-177,042,000 | $-111,779,000 | $-63,779,116 | $-40,370,040 |
| Repayment Of Debt | - | $0 | $-2,449 | $-5,850 |
| Long Term Debt Payments | - | $0 | $-2,449 | $-5,850 |
| Sale Of PPE | - | - | - | $0 |
| Change In Interest Payable | - | - | - | $-142,928 |
| Change In Receivables | - | - | - | $95,099 |
| Gain Loss On Sale Of PPE | - | - | - | $0 |
| Change In Other Working Capital | - | - | - | - |
Fetched: 2026-08-28